Epoxyeicosatrienoic Acids Function as Selective, Endogenous Antagonists of Native Thromboxane Receptors: Identification of a Novel Mechanism of Vasodilation

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2009-01-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1124/jpet.108.145102PMID 18836067
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• N-((1S)-1-{[4-((2S)-2-{[2,4-Dichlorophenyl)sulfonyl]amino} -3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl-1-benzothiophene-2- carboxamide (GSK1016790A), a novel and potent transient receptor potential vanilloid 4 channel agonist induces urinary bladder contraction and hyperactivity: Part

  2011cited by this paper
• N-((1S)-1-{[4-((2S)-2-{[(2,4-Dichlorophenyl)sulfonyl]amino}-3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide (GSK1016790A), a Novel and Potent Transient Receptor Potential Vanilloid 4 Channel Agonist Induces Urinary Bladder Contraction and Hyperactivity: Part

  2008cited by this paper
• Characterization of Epoxyeicosatrienoic Acid Binding Site in U937 Membranes Using a Novel Radiolabeled Agonist, 20-125I-14,15-Epoxyeicosa-8(Z)-Enoic Acid

  2008cited by this paper
• Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease

  2008cited by this paper
• Action of epoxyeicosatrienoic acids on cellular function.

  2007cited by this paper
• CYP2J2 and CYP2C8 polymorphisms and coronary heart disease risk: the Atherosclerosis Risk in Communities (ARIC) study

  2007cited by this paper
• Beyond vasodilatation: non-vasomotor roles of epoxyeicosatrienoic acids in the cardiovascular system.

  2007cited by this paper
• Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: implications for soluble epoxide hydrolase inhibition.

  2006cited by this paper
• GW627368X ((N‐{2‐[4‐(4,9‐diethoxy‐1‐oxo‐1,3‐dihydro‐2H‐benzo[f]isoindol‐2‐yl)phenyl]acetyl} benzene sulphonamide): a novel, potent and selective prostanoid EP4 receptor antagonist

  2006cited by this paper
• Inhibition of soluble epoxide hydrolase reduces LPS-induced thermal hyperalgesia and mechanical allodynia in a rat model of inflammatory pain.

  2006cited by this paper
• Role of Soluble Epoxide Hydrolase in Postischemic Recovery of Heart Contractile Function

  2006cited by this paper
• Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study.

  2006cited by this paper
• Nonpeptidic urotensin‐II receptor antagonists I: in vitro pharmacological characterization of SB‐706375

  2005cited by this paper
• TRPV4 Forms a Novel Ca2+ Signaling Complex With Ryanodine Receptors and BKCa Channels

  2005cited by this paper
• An Orally Active Epoxide Hydrolase Inhibitor Lowers Blood Pressure and Provides Renal Protection in Salt-Sensitive Hypertension

  2005cited by this paper
• The soluble epoxide hydrolase gene harbors sequence variation associated with susceptibility to and protection from incident ischemic stroke.

  2005cited by this paper
• Modulation of the Ca2 Permeable Cation Channel TRPV4 by Cytochrome P450 Epoxygenases in Vascular Endothelium

  2005cited by this paper
• Overactive Bladder and Incontinence in the Absence of the BK Large Conductance Ca2+-activated K+ Channel*

  2004cited by this paper
• Enhanced Postischemic Functional Recovery in CYP2J2 Transgenic Hearts Involves Mitochondrial ATP-Sensitive K+ Channels and p42/p44 MAPK Pathway

  2004cited by this paper
• Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage.

  2004cited by this paper
• Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction.

  2003cited by this paper
• Endothelium-Derived Hyperpolarizing Factor in Human Internal Mammary Artery Is 11,12-Epoxyeicosatrienoic Acid and Causes Relaxation by Activating Smooth Muscle BKCa Channels

  2003cited by this paper
• 11,12-Epoxyeicosatrienoic Acid Attenuates Synthesis of Prostaglandin E2 in Rat Monocytes Stimulated with Lipopolysaccharide

  2003cited by this paper
• Evidence for a membrane site of action for 14,15-EET on expression of aromatase in vascular smooth muscle.

  2002cited by this paper
• Activation of Gαs Mediates Induction of Tissue-type Plasminogen Activator Gene Transcription by Epoxyeicosatrienoic Acids*

  2001cited by this paper
• The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs.

  2000cited by this paper
• Mechanism and signal transduction of 14 (R), 15 (S)-epoxyeicosatrienoic acid (14,15-EET) binding in guinea pig monocytes.

  2000cited by this paper
• Soluble Epoxide Hydrolase Regulates Hydrolysis of Vasoactive Epoxyeicosatrienoic Acids

  2000cited by this paper
• Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.

  1999cited by this paper
• Urinary concentrating function in mice lacking EP3 receptors for prostaglandin E2.

  1998cited by this paper
• Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation.

  1998cited by this paper
• Potentiation of endothelium-dependent relaxation by epoxyeicosatrienoic acids.

  1997cited by this paper
• Epoxyeicosatrienoic acids activate K+ channels in coronary smooth muscle through a guanine nucleotide binding protein.

  1997cited by this paper
• Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein.

  1997cited by this paper
• Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors.

  1996influential reference
• 5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors.

  1996cited by this paper
• Stereospecific effects of epoxyeicosatrienoic acids on renal vascular tone and K(+)-channel activity.

  1996cited by this paper
• Renal vasodilator activity of 5,6-epoxyeicosatrienoic acid depends upon conversion by cyclooxygenase and release of prostaglandins.

  1993influential reference
• Cyclooxygenase-derived metabolites of 8,9-epoxyeicosatrienoic acid are potent mitogens for cultured rat glomerular mesangial cells.

  1993cited by this paper
• Cytochrome P-450 enzyme-specific control of the regio- and enantiofacial selectivity of the microsomal arachidonic acid epoxygenase.

  1990cited by this paper
• Liver microsomal cytochrome P-450 and the oxidative metabolism of arachidonic acid.

  1981cited by this paper

• Regulation of P450-derived epoxy fatty acids in cardiovascular diseases

  2025cites this paper
• The Hunt for the Putative Epoxyeicosatrienoic Acid Receptor

  2025cites this paper
• Putative receptors and signaling pathways responsible for the biological actions of epoxyeicosatrienoic acids

  2025cites this paper
• The involvement of soluble epoxide hydrolase in the development of cardiovascular diseases through epoxyeicosatrienoic acids

  2024cites this paper
• Markers of Vascular Dysfunction in Hypertension.

  2024cites this paper
• 11,12-EET suppressed LPS induced TF expression and thrombus formation by accelerating mRNA degradation rate via strengthening PI3K-Akt signaling pathway and inhibiting p38-TTP pathway.

  2023cites this paper
• Thromboxane-induced contractile response of mesenteric arterioles is diminished in the older rats and the older hypertensive rats

  2022cites this paper
• Control of Coronary Vascular Resistance by Eicosanoids via a Novel GPCR.

  2022cites this paper
• Epoxyeicosatrienoic Acid and Prostanoid Crosstalk at the Receptor and Intracellular Signaling Levels to Maintain Vascular Tone

  2022cites this paper
• Endothelium‐dependent contraction: The non‐classical action of endothelial prostacyclin, its underlying mechanisms, and implications

  2021cites this paper
• TPPU treatment of burned mice dampens inflammation and generation of bioactive DHET which impairs neutrophil function

  2021cites this paper
• Neurovascular Coupling in Development and Disease: Focus on Astrocytes

  2021cites this paper
• Discovery of novel heterocyclic amide-based inhibitors: an integrative in-silico approach to targeting soluble epoxide hydrolase

  2021influential citation
• Interactive Effects of Omega-3 Polyunsaturated Fatty Acids and Secondhand Smoke in Mice and Human Subjects

  2020cites this paper
• 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters hepatic polyunsaturated fatty acid metabolism and eicosanoid biosynthesis in female Sprague-Dawley rats.

  2020cites this paper
• Higher Epoxyeicosatrienoic Acids in Cardiomyocytes-Specific CYP2J2 Transgenic Mice Are Associated with Improved Myocardial Remodeling

  2020cites this paper
• Cytochrome P450 Metabolism of Polyunsaturated Fatty Acids and Neurodegeneration

  2020cites this paper
• CYP-derived eicosanoids: Implications for rheumatoid arthritis.

  2019cites this paper
• Thromboxane–prostaglandin receptor antagonist, terutroban, prevents neurovascular events after subarachnoid haemorrhage: a nanoSPECT study in rats

  2019cites this paper
• Lipid mediators in immune regulation and resolution

  2019cites this paper
• Prostaglandins and Other Lipid Mediators Cytochrome P450 derived epoxidized fatty acids as a therapeutic tool against neuroinflammatory diseases.

  2019cites this paper
• Oxidized Lipids in Persistent Pain States

  2019cites this paper
• Protection against acute kidney injury is afforded by a 14,15‐epoxy‐eicosatrienoic acid (EET) analog—A potential druggable pathway

  2019cites this paper
• CYP2J2 Expression in Adult Ventricular Myocytes Protects Against Reactive Oxygen Species Toxicity

  2018cites this paper
• GPCRs in context: sexual dimorphism in the cardiovascular system

  2018cites this paper
• GPR40 is a low-affinity epoxyeicosatrienoic acid receptor in vascular cells

  2018cites this paper
• CYP 2 J 2 expression in adult ventricular myocytes protects against ROS toxicity

  2018cites this paper
• Discovery of Novel Soluble Epoxide Hydrolase Inhibitors as Potent Vasodilators

  2018cites this paper
• Oxygenated Fatty Acids Enhance Hematopoiesis via the Receptor GPR132

  2017cites this paper
• Therapeutic potential of omega‐3 fatty acid‐derived epoxyeicosanoids in cardiovascular and inflammatory diseases

  2017cites this paper
• CYP2J2 metabolites, epoxyeicosatrienoic acids, attenuate Ang II-induced cardiac fibrotic response by targeting Gα12/13[S]

  2017cites this paper
• P450 Eicosanoids and Reactive Oxygen Species Interplay in Brain Injury and Neuroprotection

  2017influential citation
• 11,12 ‐Epoxyeicosatrienoic acid (11,12 EET) reduces excitability and excitatory transmission in the hippocampus

  2017cites this paper
• Orally Active Epoxyeicosatrienoic Acid Analogs.

  2017cites this paper
• Effet protecteur des acides gras polyinsaturés n-3 sur la neuroinflammation : implication des dérivés lipidiques

  2017cites this paper
• Cytochrome P450‐derived eicosanoids and heart function

  2017cites this paper
• bronchiTP-receptor agonist-induced tension in human Improved bioavailability of epoxyeicosatrienoic acids

  2016cites this paper
• CYP2J2 – regulation, function and polymorphism

  2016cites this paper
• The effect of ageing on perivascular adipose tissue function

  2016cites this paper
• Lipid Mediators in Inflammation

  2016cites this paper
• Thinking inside and outside the blood vessel: S1P-mediated control of vascular tone and the impact of CMV infection

  2016cites this paper
• Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolism.

  2015cites this paper
• Thromboxane synthase deficiency improves insulin action and attenuates adipose tissue fibrosis.

  2015cites this paper
• P450 Enzymes in Lipid Oxidation

  2015cites this paper
• The Pharmacology of the Cytochrome P 450 Epoxygenase / Soluble Epoxide Hydrolase Axis in the Vasculature and Cardiovascular Disease

  2014influential citation
• The Pharmacology of the Cytochrome P450 Epoxygenase/Soluble Epoxide Hydrolase Axis in the Vasculature and Cardiovascular Disease

  2014cites this paper
• Insight into the binding modes and inhibition mechanisms of adamantyl-based 1,3-disubstituted urea inhibitors in the active site of the human soluble epoxide hydrolase

  2014cites this paper
• Blood Oxygenated Level Dependent functional Magnetic Resonance Imaging (BOLD fMRI) and Local Field Potentials in the hippocampus of mice lacking IP3-dependent calcium signalling in astrocytes

  2014cites this paper
• Interactions between thromboxane A₂, thromboxane/prostaglandin (TP) receptors, and endothelium-derived hyperpolarization.

  2014cites this paper
• PHARMREV007781 1106..1140

  2014influential citation
• Identification and Functional Characterization of CNS Pericytes and the Role they Play in Neurovascular Coupling in Physiological and Pathological Conditions

  2013cites this paper
• Metabolic products of soluble epoxide hydrolase are essential for monocyte chemotaxis to MCP-1 in vitro and in vivo

  2013cites this paper
• Neurophysiological, metabolic and cellular compartments that drive neurovascular coupling and neuroimaging signals

  2013cites this paper
• Dual modulation of cyclooxygenase and CYP epoxygenase metabolism and acute vascular inflammation in mice.

  2013cites this paper
• Eicosanoids in metabolic syndrome.

  2013cites this paper
• Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health.

  2013cites this paper
• Molecular biology of atherosclerosis.

  2013cites this paper
• Endothelial 12(S)-HETE vasorelaxation is mediated by thromboxane receptor inhibition in mouse mesenteric arteries.

  2013cites this paper
• Roles of endothelial nitric oxide synthase (eNOS) and mitochondrial permeability transition pore (MPTP) in epoxyeicosatrienoic acid (EET)-induced cardioprotection against infarction in intact rat hearts.

  2013cites this paper
• Impact of Soluble Epoxide Hydrolase and Epoxyeicosanoids on Human Health

  2013cites this paper
• Disruption of soluble epoxide hydrolase dimerization as a novel therapeutic target for stroke

  2013cites this paper
• Papel de la cascada del ácido araquidónico en la función epitelial de barrera en un modelo de células intestinales Caco-2

  2013cites this paper
• Basal omega-3 fatty acid status affects fatty acid and oxylipin responses to high-dose n3-HUFA in healthy volunteers[S]

  2012cites this paper
• An eicosanoid-centric view of atherothrombotic risk factors

  2012cites this paper
• Design, synthesis and evaluation of non-urea inhibitors of soluble epoxide hydrolase.

  2012cites this paper
• Soluble epoxide hydrolase inhibitors and cardiovascular diseases.

  2012cites this paper
• Soluble Epoxide Hydrolase as a Stroke Target

  2012cites this paper
• Epoxides and soluble epoxide hydrolase in cardiovascular physiology.

  2012cites this paper
• Contribution of Flow-Dependent Vasomotor Mechanisms to the Autoregulation of Cerebral Blood Flow

  2012cites this paper
• The Endothelium, Part II: EDHF-Mediated Responses "The Classical Pathway"

  2011cites this paper
• Conséquences fonctionnelles de l'inhibition de l'époxyde hydrolase soluble sur la biodisponibilité des époxy-éicosanoïdes dans les muscles lisses du poumon humain

  2011influential citation
• EETs and Oxo-ETE in Airway Diseases

  2011cites this paper
• Analgesia mediated by soluble epoxide hydrolase inhibitors is dependent on cAMP

  2011cites this paper
• Prostaglandins and Inflammation

  2011cites this paper
• Role of cytochrome P450 (CYP) metabolites of arachidonic acid in the regulation of cAMP in HEK293 cells

  2011cites this paper
• Endothelium‐mediated control of vascular tone: COX‐1 and COX‐2 products

  2011cites this paper
• Metabolism and Roles of Eicosanoids in Brain

  2011cites this paper
• The ω‐3 epoxide of eicosapentaenoic acid inhibits endothelial cell proliferation by p38 MAP kinase activation and cyclin D1/CDK4 down‐regulation

  2011cites this paper
• Soluble epoxide hydrolase: a promising therapeutic target for cardiovascular diseases.

  2011cites this paper
• 20-Iodo-14,15-epoxyeicosa-8(Z)-enoyl-3-azidophenylsulfonamide: photoaffinity labeling of a 14,15-epoxyeicosatrienoic acid receptor.

  2011influential citation
• The physiology of developmental changes in BOLD functional imaging signals.

  2011cites this paper
• Modulation of cytochrome-derived epoxyeicosatrienoic acids pathway: a promising pharmacological approach to prevent endothelial dysfunction in cardiovascular diseases?

  2011cites this paper
• International Union of Basic and Clinical Pharmacology. LXXXIII: Classification of Prostanoid Receptors, Updating 15 Years of Progress

  2011influential citation
• Old and new generation lipid mediators in acute inflammation and resolution.

  2011cites this paper
• Improved bioavailability of epoxyeicosatrienoic acids reduces TP-receptor agonist-induced tension in human bronchi.

  2011cites this paper
• Modulation of neurovascular coupling in the retina:effects of oxygen and diabetic retinopathy.

  2011cites this paper
• Chronic treatment with epoxyeicosatrienoic acids modulates insulin signaling and prevents insulin resistance in hepatocytes.

  2011cites this paper
• The cytochrome P450 pathway in angiogenesis and endothelial cell biology

  2011cites this paper
• The Endothelium, Part I: Multiple Functions of the Endothelial Cells -- Focus on Endothelium-Derived Vasoactive Mediators

  2011cites this paper
• JPET # 169748 2 RUNNING TITLE PAGE Running Title : Selexipag and gastric function Corresponding

  2010influential citation
• The role of P450 epoxyeicosanoids in cerebral extrinsic perivascular vasodilator nerve function.

  2010cites this paper
• Pharmacological inhibition of the soluble epoxide hydrolase-from mouse to man.

  2010cites this paper
• Epoxyeicosanoid signaling in CNS function and disease.

  2010cites this paper
• Endothelial dysfunction: a strategic target in the treatment of hypertension?

  2010cites this paper
• Evidence for a role of opioids in epoxyeicosatrienoic acid-induced cardioprotection in rat hearts.

  2010cites this paper
• Endothelium-derived hyperpolarising factors and associated pathways: a synopsis

  2010cites this paper
• Epoxyeicosatrienoic acids and endothelium-dependent responses

  2010cites this paper
• The thromboxane/endoperoxide receptor (TP): the common villain.

  2010cites this paper
• Development of a High Throughput Cell-Based Assay for Soluble Epoxide Hydrolase Using BacMam Technology

  2010cites this paper
• Glial and neuronal control of brain blood flow

  2010cites this paper